Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Deep brain stimulation for other tremors, myoclonus, and chorea.
Trigeminal neuralgia: A new therapy?
Il-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis.
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis.
Immunology of neuromyelitis optica: a T cell-B cell collaboration.
Use of Functional Ambulation Performance Score as measurement of gait ability: Review.
Morning serum melatonin values in multiple sclerosis: A biochemical evaluation.
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Identification of a Selective RORγ Ligand That Suppresses T(H)17 Cells and Stimulates T Regulatory Cells.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Fulminant Demyelinating Diseases of the Central Nervous System.
Plasmablast in the pathology of multiple sclerosis.
Clinical trials in multiple sclerosis.
Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Lead Candidate (MIS416) Overview
TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3(+) Treg cells.
Opexa Therapeutics reports third quarter 2013 financial results and provides corporate update
Neuroimaging biomarkers of neurodegenerative diseases and dementia.
Histamine H2 receptor signaling x environment interactions determine susceptibility to experimental allergic encephalomyelitis.
S1P signaling: new therapies and opportunities.
Pages
« first
‹ previous
…
409
410
411
412
413
414
415
416
417
…
next ›
last »